5 research outputs found
Assessing Exposome Effects on Pregnancy through Urine Metabolomics of a Portuguese (Estarreja) Cohort
This
nuclear magnetic resonance metabolomics study compared the
influence of two different central Portugal exposomes, one of which
comprised an important source of pollutants (the Estarreja Chemical
Complex, ECC), on the urinary metabolic trajectory of a cohort of
healthy pregnant women (total <i>n</i> = 107). An exposome-independent
description of pregnancy metabolism was found to comprise a set of
18 metabolites reflecting expected changes in branched-chain amino
acid catabolism and hormone and lipid metabolisms. In addition, a
set of small changes in some metabolites was suggested to be exposome-dependent
and characteristic of pregnant subjects from the Estarreja region.
These results suggested that the Estarreja exposome may impact to
a very low extent pregnancy metabolism, inducing slight changes in
amino acid metabolism (alanine, glycine, and 3-hydroxyisobutyrate,
possibly involved in valine metabolism), tricarboxylic acid (TCA)
cycle (<i>cis</i>-aconitate), diet, or gut microflora (furoylglycine)
as well as allantoin, 2-hydroxyisobutyrate, and an unassigned resonance
at Ī“ 8.45. Furthermore, the urine of Estarreja subjects was
found to generally contain higher levels of 4-hydroxyphenylacetate
and lower levels of citrate. However, out of the above metabolites,
only glycine and citrate seemed to correlate with the proximity to
the ECC, with slightly relative higher levels of these compounds found
for subjects living closer to the ECC. This suggested possible small
effects of local pollutants on energy metabolism, with the remaining
exposome-dependent metabolite changes most probably originating from
other aspects of the local exposome such as diet and lifestyle. Despite
the limitation of this study regarding the unavailability of objective
environmental parameters for the period under study, our results confirm
the usefulness of metabolomics of human urine to gauge exposome effects
on human health and, particularly, during pregnancy
Ohmic Heating-Assisted Synthesis of 3āArylquinolin-4(1<i>H</i>)āones by a Reusable and Ligand-Free SuzukiāMiyaura Reaction in Water
Potential bioactive 3-arylquinolin-4Ā(1<i>H</i>)-ones
were synthesized under ohmic heating using an efficient, reusable,
and ligand-free protocol developed for the SuzukiāMiyaura coupling
of 1-substituted-3-iodoquinolin-4Ā(1<i>H</i>)-ones with several
boronic acids in water using PdĀ(OAc)<sub>2</sub> as a catalyst and
tetrabutylammonium bromide (TBAB) as the phase transfer catalyst.
Good substrate generality, ease of execution, short reaction time,
and practicability make this method exploitable for the generation
of libraries of B ring-substituted 3-arylquinolin-4Ā(1<i>H</i>)-ones. After a simple workup, the Pd/catalyst-H<sub>2</sub>O-TBAB
system could be reused for at least seven cycles without significant
loss of activity
Prediction of Gestational Diabetes through NMR Metabolomics of Maternal Blood
Metabolic biomarkers of pre- and
postdiagnosis gestational diabetes
mellitus (GDM) were sought, using nuclear magnetic resonance (NMR)
metabolomics of maternal plasma and corresponding lipid extracts.
Metabolite differences between controls and disease were identified
through multivariate analysis of variable selected <sup>1</sup>H NMR
spectra. For postdiagnosis GDM, partial least squares regression identified
metabolites with higher dependence on normal gestational age evolution.
Variable selection of NMR spectra produced good classification models
for both pre- and postdiagnostic GDM. Prediagnosis GDM was accompanied
by cholesterol increase and minor increases in lipoproteins (plasma),
fatty acids, and triglycerides (extracts). Small metabolite changes
comprised variations in glucose (up regulated), amino acids, betaine,
urea, creatine, and metabolites related to gut microflora. Most changes
were enhanced upon GDM diagnosis, in addition to newly observed changes
in low-<i>M</i><sub>w</sub> compounds. GDM prediction seems
possible exploiting multivariate profile changes rather than a set
of univariate changes. Postdiagnosis GDM is successfully classified
using a 26-resonance plasma biomarker. Plasma and extracts display
comparable classification performance, the former enabling direct
and more rapid analysis. Results and putative biochemical hypotheses
require further confirmation in larger cohorts of distinct ethnicities
Following Healthy Pregnancy by NMR Metabolomics of Plasma and Correlation to Urine
This
work presents the first NMR metabolomics study of maternal
plasma during pregnancy, including correlation between plasma and
urine metabolites. The expected decrease in circulating amino acids
early in pregnancy was confirmed with six amino acids being identified
as required by the fetus in larger extents. Newly observed changes
in citrate, lactate, and dimethyl sulfone suggested early adjustments
in energy and gut microflora metabolisms. Alterations in creatine
levels were also noted, in addition to creatinine variations reflecting
alterations in glomerular filtration rate. Regarding plasma macromolecules,
HDL and LDL+VLDL levels were confirmed to increase throughout pregnancy,
although at different rates and accompanied by increases in fatty
acid chain length and degree of unsaturation. Correlation studies
suggested (a) an inverse relationship between lipoproteins (HDL and
LDL+VLDL) and albumin, with a possible direct correlation to excreted
(unassigned) pregnancy markers resonating at Ī“ 0.55 and Ī“
0.63, (b) a direct link between LDL+VLDL and <i>N</i>-acetyl-glycoproteins,
together with excreted marker at Ī“ 0.55, and (c) correlation
of plasma albumin with particular circulating and excreted metabolites.
These results have unveiled specific lipoprotein/protein metabolic
aspects of pregnancy with impact on the excreted metabolome and, therefore,
provide an interesting lead for the further understanding of pregnancy
metabolism
Intestinal Microbial and Metabolic Profiling of Mice Fed with High-Glucose and High-Fructose Diets
Increased sugar intake
is implicated in Type-2 diabetes and fatty
liver disease; however, the mechanisms through which glucose and fructose
promote these conditions are unclear. We hypothesize that alterations
in intestinal metabolite and microbiota profiles specific to each
monosaccharide are involved. Two groups of six adult C57BL/6 mice
were fed for 10-weeks with diets with glucose (G) or fructose (F)
as sole carbohydrates, and a third group was fed with a normal chow
carbohydrate mixture (N). Fecal metabolites were profiled by nuclear
magnetic resonance (NMR) and microbial composition by real-time polymerase
chain reaction (qPCR). Although N, G and F mice exhibited similar
weight gains (with slight slower gains for F) and glucose tolerance,
multivariate analysis of NMR data indicated that F mice were separated
from N and G, with decreased butyrate and glutamate and increased
fructose, succinate, taurine, tyrosine, and xylose. The different
sugar diets also resulted in distinct intestinal microbiota profiles.
That associated with fructose seemed to hold more potential to induce
host metabolic disturbances compared to glucose, mainly by promoting
bile acid deconjugation and taurine release and compromising intestinal
barrier integrity. This may reflect the noted nonquantitative intestinal
fructose absorption hence increasing its availability for microbial
metabolism, a subject for further investigation